Subfatin, asprosin, alamandine and maresin-1 in cerebral ischemia, intracranial and subarachnoid hemorrhages

dc.contributor.authorAlbayrak, S.
dc.contributor.authorAydin, M. A.
dc.contributor.authorUgur, K.
dc.contributor.authorHanbeyoglu, O.
dc.contributor.authorAydin, S.
dc.contributor.authorErol, E.
dc.contributor.authorAydin, S.
dc.date.accessioned2026-08-12T16:58:00Z
dc.date.issued2023
dc.departmentFırat Üniversitesi
dc.description.abstract- OBJECTIVE: Cerebrovascular diseases (CVDs) remain an important public health issue due to the increasing number of deaths worldwide. Changes in the synthesis and release of peptides in CVDs may play an im-portant role in elucidating the physiopathology
dc.identifier.endpage4480
dc.identifier.issn1128-3602
dc.identifier.issue10
dc.identifier.pmid37259728
dc.identifier.scopus2-s2.0-85160789219
dc.identifier.scopusqualityN/A
dc.identifier.startpage4471
dc.identifier.urihttps://hdl.handle.net/11508/46666
dc.identifier.volume27
dc.identifier.wosWOS:001021187100018
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherVerduci Publisher
dc.relation.ispartofEuropean Review for Medical and Pharmacological Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectMaresin-1
dc.subjectSubfatin
dc.subjectAsprosin
dc.subjectAlamandine
dc.subjectCere-bral ischemia
dc.subjectHemorrhagy
dc.titleSubfatin, asprosin, alamandine and maresin-1 in cerebral ischemia, intracranial and subarachnoid hemorrhages
dc.typeArticle

Dosyalar